Developing the world’s 1st scalable, end-to-end system for cost-efficient, sustainable cultivated pork meat production

开发世界上第一个可扩展的端到端系统，以实现经济高效、可持续的养殖猪肉生产

• 批准号: 10079403
• 金额: $ 44.54万
• 依托单位: CELLCRAFT LTD
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2024
• 资助国家: 英国
• 起止时间: 2024 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=10079403
• 关键词: Developing; world; 1st; scalable; end

Global food systems need to produce 50% more food to sustain growing populations over the next 40 years, whilst substantially reducing greenhouse gas (GHG) emissions (Social Market Foundation,2020). 14% of total emissions are attributable to animal farming. Without changes throughout the value chain, these emissions are likely to increase by 30-40% by 2050(IPCC,2020).Cultivated meat (CM) can be a safe and sustainable alternative to animal farming. Pork is the most widely consumed meat(UN-FAO,2020). Cultivated pork is estimated to have -75% GHG emissions and -72% land requirements(Good Food Institute,2021). While production costs are currently 100-10,000x higher than for animal-farmed products, with the right scale-up technologies, prices could reach a competitive point before 2030\. Progress in the industry has been slow, but in the last decade, CM has gone from its 1st burger costing \>$250,000 in 2013 to cultivated chicken being approved in the USA and sold in Singapore by 2023\.Animal Alternative Technologies(AAT) is a B2B company located at the University of Cambridge. We are creating a scalable, end-to-end system for CM production, including specialist bioprocesses, enabling technologies, and software. Our mission is to democratise access to sustainable food and tackle the world's biggest sustainability and food security challenges. Our collaboration with Cellivate during this R&D project aims to develop the world's 1st end-to-end, cost-efficient cultivated pork production system that enables meat producers to commercially manufacture at large scales their own tailored, cultivated pork products, which are nutritious, delicious for general consumption, with lower environmental impact, higher quality, stronger local supply chains, and ethical sources. We will do this by optimizing and combining our non-GMO cell lines with Cellivate's proprietary 10x cheaper animal-component-free media and customized edible scaffolds in our novel, scalable purpose-built bioreactors, and then scaling up.To date, we have raised \>£3 million from VCs and strategic investors, and have developed several patents/pioneering technologies, including cell lines and bioelectronic sensors. Our work has received multiple awards, and AAT has participated in 4 accelerators. We have been featured in TechCrunch, Food Navigator, The Spoon, etc., and are focused on food security and sustainability. Cellivate has developed patented nanotech technologies that enable cells to grow better and faster. Their portfolio includes edible scaffolds, biomaterials and serum-free media, which accelerate CM development. Cellivate was in the Good Food Institute's "2020 Asia Alt 100" list. It has received awards/recognition from Mitsui Chemicals, ASPIRE Labs and has been featured in multiple publications and podcasts.

全球粮食系统需要在未来 40 年多生产 50% 的粮食来维持不断增长的人口，同时大幅减少温室气体 (GHG) 排放（社会市场基金会，2020 年）。在整个价值链中，到 2050 年，这些排放量可能会增加 30-40%（IPCC，2020）。人造肉 (CM) 可以成为畜牧业的安全且可持续的替代品。猪肉是消费最广泛的肉类（联合国粮农组织，2020 年），预计养殖猪肉的温室气体排放量为 -75%，土地需求量为 -72%（Good Food Institute，2021 年），而目前的生产成本高出 100-10,000 倍。与动物养殖产品相比，如果采用适当的规模化技术，价格可能会在 2030 年之前达到有竞争力的水平。该行业的进展缓慢，但在过去十年中，CM 已经取得了进展。从 2013 年第一个售价超过 25 万美元的汉堡，到 2023 年在美国获得批准并在新加坡销售的培育鸡。动物替代技术 (AAT) 是一家位于剑桥大学的 B2B 公司，我们正在创建一个可扩展的、我们的使命是实现可持续食品的民主化并解决世界面临的问题。我们在这个研发项目中与 Cellivate 的合作旨在开发世界上第一个端到端、经济高效的养殖猪肉生产系统，使肉类生产商能够大规模商业化生产自己定制的养殖猪肉。我们将通过优化和结合我们的非转基因道德细胞系与 Cellivate 专有的道德标准来实现这一目标。在我们新颖的、可扩展的专用生物反应器中使用便宜 10 倍的无动物成分培养基和定制的可食用支架，然后扩大规模。迄今为止，我们已从风险投资和战略投资者那里筹集了超过 300 万英镑，并开发了多项专利/我们的工作获得了多项奖项，并且 AAT 参与了 4 个加速器项目，并在 TechCrunch、Food Navigator 和 The 上得到了专题报道。 Spoon 等公司专注于食品安全和可持续发展，他们开发了专利纳米技术，使细胞能够更好更快地生长。他们的产品组合包括可食用支架、生物材料和无血清培养基，从而加速了 CM 的开发。 Good Food Institute 的“2020 年亚洲 Alt 100”名单已获得三井化学、ASPIRE Labs 的奖项/认可，并在多个出版物和播客中得到专题报道。